EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma






Cancer Cell 20(2): 229-245

ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma

Proinflammatory cytokines are frequently observed in the tumor microenvironment, and chronic inflammation is involved in cancer initiation and progression. We show that cytokine signaling through the receptor subunit GP130-IL6ST and the kinase JAK1 generates actomyosin contractility through Rho-kinase dependent signaling. This pathway generates contractile force in stromal fibroblasts to remodel the extracellular matrix to create tracks for collective migration of squamous carcinoma cells and provides the high levels of actomyosin contractility required for migration of individual melanoma cells in the rounded, "amoeboid" mode. Thus, cytokine signaling can generate actomyosin contractility in both stroma and tumor cells. Strikingly, actomyosin contractility itself positively modulates activity of the transcription factor STAT3 downstream of JAK1, demonstrating positive feedback within the signaling network.


Accession: 055338095

PMID: 21840487

DOI: 10.1016/j.ccr.2011.06.018



Related references

Kümper, S.; Marshall, C.J., 2011: ROCK-driven actomyosin contractility induces tissue stiffness and tumor growth. The tumor environment consists of tumor-associated cells, such as macrophages, fibroblasts, and extracellular matrix, and has an important impact on tumor progression. In this issue of Cancer Cell, Samuel et al. show that ROCK-driven actomyosin c...

Rodriguez-Hernandez, I.; Cantelli, G.; Bruce, F.; Sanz-Moreno, V., 2016: Rho, ROCK and actomyosin contractility in metastasis as drug targets. Metastasis is the spread of cancer cells around the body and the cause of the majority of cancer deaths. Metastasis is a very complex process in which cancer cells need to dramatically modify their cytoskeleton and cope with different environments...

Song, L.; Rawal, B.; Nemeth, J.A.; Haura, E.B., 2011: JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling. Members of the signal transducer and activator of transcription (STAT) family of transcription factors are potential targets for the treatment and prevention of cancers including non-small-cell lung cancer. STAT proteins can be phosphorylated and...

Li, W.; Huang, P.; Chen, D.J.; Gerweck, L.E., 2015: Determinates of tumor response to radiation: tumor cells, tumor stroma and permanent local control. RadioTherapy and Oncology 113(1): 146-149

Lee, J-Yi.; Marston, D.J.; Walston, T.; Hardin, J.; Halberstadt, A.; Goldstein, B., 2006: Wnt/Frizzled signaling controls C. elegans gastrulation by activating actomyosin contractility. Background: Embryonic patterning mechanisms regulate the cytoskeletal machinery that drives morphogenesis, but there are few cases where links between patterning mechanisms and morphogenesis are well understood. We have used a combination of gene...

Lee, J.-Yi; Marston, D., J.; Walston, T.; Hardin, J.; Halberstadt, A.; Goldstein, B., 2006: Wnt/Frizzled signaling controls C-elegans gastrulation by activating actomyosin contractility. Background: Embryonic patterning mechanisms regulate the cytoskeletal machinery that drives morphogenesis, but there are few cases where links between patterning mechanisms and morphogenesis are well understood. We have used a combination of gene...

Miscia, S.; Marchisio, M.; Grilli, A.; D.V.lerio, V.; Centurione, L.; Sabatino, G.; Garaci, F.; Zauli, G.; Bonvini, E.; D.B.ldassarre, A., 2002: Tumor necrosis factor alpha (TNF-alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. The biological actions of tumor necrosis factor alpha (TNF-alpha) are mediated by two cell surface receptors, TNFR-1 and TNFR-2. These receptors do not display protein tyrosine kinase activity. Nevertheless, an early TNF-induced activation of spec...

Gallo, G.; Letourneau, P.C., 2000: Jasplakinolide induced axon retraction is mediated by actomyosin contractility and regulated by the tonic activity of the Rho-ROCK pathway. Molecular Biology of the Cell 11(Supplement): 179a, Dec

Ivanov, A.I.; Samarin, S.N.; Bachar, M.; Parkos, C.A.; Nusrat, A., 2009: Protein kinase C activation disrupts epithelial apical junctions via ROCK-II dependent stimulation of actomyosin contractility. Disruption of epithelial cell-cell adhesions represents an early and important stage in tumor metastasis. This process can be modeled in vitro by exposing cells to chemical tumor promoters, phorbol esters and octylindolactam-V (OI-V), known to act...

Flynn, P.G.; Helfman, D.M., 2010: Non-muscle myosin IIB helps mediate TNF cell death signaling independent of actomyosin contractility (AMC). Non-muscle myosin II (NM II) helps mediate survival and apoptosis in response to TNF-alpha (TNF), however, NM II's mechanism of action in these processes is not fully understood. NM II isoforms are involved in a variety of cellular processes...